Fetal valproate syndrome Case Report

Year 2009, Volume: 44 Issue: 3, 6 - 8, 01.09.2009

Derya Kalyoncu Ümran Çetinçelik Feyzullah Çetinkaya

Abstract

Fetal valproate syndrome which is seen in children of epileptic mothers who have taken sodium valproate during their pregnancy is characterized by typical facial appearance major and minor malformations and neurodevelopmental delay A case with facial features including epicanthal folds depressed nasal bridge hypertelorism retrognathia low set ears and peripheral pulmonary artery stenosis patent ductus arteriosus and overlapping toes is presented for reminding this syndrome Turk Arch Ped 2009; 44: 106 8 Key words: Congenital malformations fetal valproate syndrome sodium valproate

Keywords

-

Fetal valproat sendromu Olgu Sunumu

Abstract

Fetal valproat sendromu gebeliklerinde sodyum valproat kullanan epilepsili annelerin çocuklarında görülen tipik yüz görünümü önemli veya hafif malformasyonlar ve nöromotor gelişme geriliği ile beliren sendromdur Epikantus basık burun kökü retrognati düşük kulak ve hipertelorizmi içeren yüz bulguları periferik pulmoner arter darlığı patent duktus arteriyozus ve ayak parmaklarında anomali saptanan bir olgu sunulmuştur Türk Ped Arş 2009; 44: 106 8 Anahtar kelimeler: Doğumsal malformasyonlar fetal valproat sendromu sodyum valproat

Keywords

Doğumsal malformasyonlar, fetal valproat sendromu, sodyum valproat

References

• Kozma C. Valproic acid embryopathy: report of two siblings with further expantion of the phenotypic abnormalities and a review of the literature. Am J Med Genet 2001:15; 98: 168- 75. (Abstract) / (Full Text) / (PDF)
• Malm H, Kajantie E, Kivirikko S, Kääriäinen H, Peippo M, So- mer M. Valproate embryopathy in three sets of siblings: furt- her proof of hereditary susceptibility. Neurology 2002; 59: 630-3. (Abstract) / (Full Text) / (PDF)
• Di Liberti JH, Farndon PA, Dennis NR, Curry CJ. The fetal valproate syndrome. Am J Med Genet 1984; 19: 473-81. (Abstract) / (Full Text)
• Clayton –Smith J, Donnai D. Fetal valproate syndrome. J Med Genet 1995; 32: 724-7. (Abstract) / (Full Text)
• Ardinger Holly H, Atkin Joan F, Blackston Dwain R , et al. Ve- rification of the fetal valproate syndrome phenotype. Am J Med Genet 1988; 29: 171-8. (Abstract) / (Full Text)
• Kini U, Adab N, Vinten J, Fryer A, Clayton-Smith J. Dysmorp- hic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes. Arch Dis Child Fetal Ne- onatal Ed 2006; 91: F90-5. (Abstract) / (Full Text) / (PDF)
• Dalens B, Raynaud EJ, Gaulme J. Teratogenicity of valproic acid. J Pediatr 1980; 97: 332-3. (Full Text)
• Winter RM, Donnai D, Burn J, Tucker SM. Fetal valproate syndrome: is there a recognisable phenotype? J Med Genet 1987; 24: 692-5. (Abstract) / (Full Text)
• Briggs Gerald G, Freeman Roger K, Yaffe Sumner J. Drugs in Pregnancy and Lactation . 7th ed. Philadelphia : Lippincott Williams & Wilkins 2005: 1689-96. (Abstract)
• Kulkami ML, Zaheeruddin M, Shenoy N, Vani HN. Fetal valproa- te syndrome. Indian J Pediatr 2006; 73: 937-9. (Abstract) / (PDF)
• Carrim ZI, Mckay L, Sidiki SS, Lavy TE. Early intervention for the ocular and neurodevelopmental sequelae of fetal val- proate syndrome. J Paediatr Child Health 2007; 43: 643-5. (Abstract)
• Williams G, King J, Cunningham M, Stephan M, Kerr B, Hersh JH. Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol 2001; 43:202-6. (Abstract)
• Diav-Citrin O, Shechtman S, Bar-Oz B, Cantrell D, Arnon J, Ornoy A. Pregnancy outcome after in utero exposure to val- proate : evidence of dose relationship in teratogenic effect. CNS Drugs 2008; 22: 325-34. (Abstract)
• Guven MA, Batukan C, Ceylaner S, Ceylaner G, Uzel M. A case of fetal anticonvulsant syndrome with severe bilateral upper limb defect. J Matern Fetal Neonatal Med 2006;19: 115-7. (Abstract)
• TTüürrkk PPeedd AArrşş 22000099;; 4444:: 110066--88
• TTuurrkk AArrcchh PPeedd 22000099;; 4444:: 110066--88
• Fetal valproat sendromu